Quantum BioPharma’s unbuzzd Goes Ultra-Portable with Celly Nutrition’s New Retail Push
DENVER, Colo., Mar 26, 2025 (247marketnews.com)- Quantum BioPharma’s (NASDAQ:QNTM) licensee, Celly Nutrition, rolled out a sleek new lineup for unbuzzd, the alcohol detox drink that speeds metabolism, sharpens focus, and kicks hangovers to the curb. Ultra-portable powder sticks in eye-catching 8-pack display boxes, now hitting U.S. convenience, liquor, and drug stores, and are already live on amazon.com and unbuzzd.com.
John Duffy, Celly Nutrition’s CEO, said, “The 8-pack display box enhances unbuzzd’s package evolution, meeting various consumer needs and accelerating retail availability across the United States. This new format aims to boost sales and profits for retailers in the estimated $2.1 billion global hangover cure products market. Channel distribution at popular brick-and-mortar stores is expected to be a key growth driver for unbuzzd with the convenience of immediate availability for customers.”
Celly Nutrition’s unbuzzd, a ready-to-mix powder that’s won fans for its post-party punch, now comes in 3-packs, 8-packs, and 18-packs. The 8-pack, a slim 2-inch-wide marvel with bold packaging and built-in point-of-sale flair, is tailor-made for register impulse buys.
Gerry David, Co-Chair and former CEO of Celsius, commented, “With our recent clinical trial proving the effectiveness of unbuzzd™ in reducing blood alcohol concentration, restoring mental clarity and reducing hangover symptoms, the single-use stick in a convenient 8-pack box is an important next step in the Company’s growth, bringing unbuzzd to retailers and consumers in multiple formats and at an affordable price.”
Quantum holds a 25% stake in Celly and rakes in 7% royalties on unbuzzd sales until hitting $250 million, then 3% forever. While Celly scales retail, Quantum keeps 100% rights to tweak unbuzzd for pharma and medical uses.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (QNTM)
- Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case
- Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT
- Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target
- Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
- Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital